Literature DB >> 3951103

The economic cost of pelvic inflammatory disease.

A E Washington, P S Arno, M A Brooks.   

Abstract

Pelvic inflammatory disease (PID) is one of the most widespread and debilitating diseases affecting women today. To calculate the economic costs of PID and PID-associated ectopic pregnancy and infertility in the United States, we analyzed data from local hospitals and from several state and national sources. Direct and indirect costs were computed. We found that the total cost of PID and PID-associated ectopic pregnancy and infertility exceeded +2.6 billion in 1984. By 1990, the estimated cost of PID and its sequelae will total +3.50 billion per year, if the annual medical care inflation is 5% and the incidence of PID remains constant during this six-year period. These estimated costs of PID and its associated sequelae emphasize the urgent need for effective programs to prevent PID.

Entities:  

Mesh:

Year:  1986        PMID: 3951103

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  17 in total

1.  Lower Genital Tract Infections and HIV in Women.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-12       Impact factor: 3.725

2.  Is it cost-beneficial to screen adolescent males for chlamydia?

Authors:  E R Alexander
Journal:  Am J Public Health       Date:  1990-05       Impact factor: 9.308

3.  Screening for Chlamydia trachomatis in adolescent males: a cost-based decision analysis.

Authors:  A G Randolph; A E Washington
Journal:  Am J Public Health       Date:  1990-05       Impact factor: 9.308

Review 4.  Vaginal douching as a possible risk factor for pelvic inflammatory disease.

Authors:  K A Forrest; A E Washington; J R Daling; R L Sweet
Journal:  J Natl Med Assoc       Date:  1989-02       Impact factor: 1.798

5.  Pelvic inflammatory disease: a family practice perspective.

Authors:  J W Sellors
Journal:  Can Fam Physician       Date:  1989-06       Impact factor: 3.275

6.  Incidence of severe reproductive tract complications associated with diagnosed genital chlamydial infection: the Uppsala Women's Cohort Study.

Authors:  N Low; M Egger; J A C Sterne; R M Harbord; F Ibrahim; B Lindblom; B Herrmann
Journal:  Sex Transm Infect       Date:  2006-06       Impact factor: 3.519

7.  Should asymptomatic patients be tested for Chlamydia trachomatis in general practice?

Authors:  H Buhaug; F E Skjeldestad; L E Halvorsen; A Dalen
Journal:  Br J Gen Pract       Date:  1990-04       Impact factor: 5.386

Review 8.  Pelvic inflammatory disease: current concepts and treatment guidelines.

Authors:  P A Dale; P A Rice; K C Edelin
Journal:  J Gen Intern Med       Date:  1986 Nov-Dec       Impact factor: 5.128

9.  Cost effectiveness analysis of azithromycin and doxycycline for Chlamydia trachomatis infection in women: A Canadian perspective.

Authors:  F Marra; C A Marra; D M Patrick
Journal:  Can J Infect Dis       Date:  1997-07

10.  Periodic health examination, 1996 update: 2. Screening for chlamydial infections. Canadian Task Force on the Periodic Health Examination.

Authors:  H D Davies; E E Wang
Journal:  CMAJ       Date:  1996-06-01       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.